Shares of Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) fell 3.9% during trading on Friday . The stock traded as low as $109.47 and last traded at $109.47. 7,297 shares were traded during trading, an increase of 853% from the average session volume of 766 shares. The stock had previously closed at $113.9150.
Analyst Ratings Changes
Separately, Jefferies Financial Group set a $155.00 price target on shares of Pro Medicus and gave the company a “buy” rating in a research report on Thursday, February 12th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $155.00.
Read Our Latest Stock Report on PMCUF
Pro Medicus Trading Down 3.9%
Pro Medicus Company Profile
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
See Also
- Five stocks we like better than Pro Medicus
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
